𝔖 Bobbio Scriptorium

✦ LIBER ✦

PIH21 IS ROUTINE IMMUNIZATION OF ELDERLY WITH THE 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE LIKELY TO BE CONSIDERED AS COST-EFFECTIVE?

✍ Scribed by MH Rozenbaum; E Hak; TS van der Werf; MJ Postma

Book ID: 118614729
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 77 KB
Volume: 13
Category: Article
ISSN: 1098-3015
DOI: 10.1016/s1098-3015(11)72536-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PIN64 Assessing the Cost-Effectiveness (

PIN64 Assessing the Cost-Effectiveness (CE) of Vaccinating the Elderly and at-Risk Adults With the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) Compared to the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) or no Vaccination (NoVac) in the UK

✍ Y. Jiang; A. Gauthier; S.T. Keeping; S.M. Carroll 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

Results of a cohort model analysis of th

Results of a cohort model analysis of the cost-effectiveness of routine immunization with 13-valent pneumococcal conjugate vaccine of those aged ≥65 years in the Netherlands

✍ Mark H. Rozenbaum; Eelko Hak; Tjip S. van der Werf; Maarten J. Postma 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 313 KB